As advised in our recent Investor Updates, distributions, comprising mostly of sale proceeds, will be paid to investors at the time that the remaining properties are sold over the next 6-12 months. Please refer to the latest Investor Update for further details.

Investor Update

An Investor Update will be sent quarterly with the Distribution Statement informing investors of recent happenings within MAB Funds and the funds.

Tax Statement

All investors will be sent an annual Tax Statement with a guide to complete their Tax Returns.

New Products

All investors will be sent information regarding new investment opportunities available from MAB Funds.

The Anti-Money Laundering and Counter-Terrorism Financing Act 2006 (AML/CTF Act) received Royal Assent on 12 December 2006. The goal of the Legislation is to prevent and detect money laundering and terrorism financing by meeting the needs of law enforcement agencies for targeted information about possible criminal activity. This is enabling Australia’s financial sector to maintain international business relationships by bringing Australia into line with international standards.

How does the Legislation affect MAB Funds Management?

As per the AML/CTF legislation, MAB Funds Management is a “reporting entity” This places a greater emphasis on investor verification & identification. This means that before units are Issued/Transferred in a Fund, MAB Funds Management must be satisfied that who you claim to be, is who you really are. This process is commonly referred to as ‘Know Your Customer” (KYC Process).

How does the Legislation affect Investors?

With the introduction of the Anti-Money Laundering & Counter-Terrorism Financing Act 2006 (AML/CTF Act) additional information and identification is required by potential & current investors. This information can be provided directly to investor’s services by you or your advisor. MAB Funds Management may be unable to process transfer requests without the complete identification document located in AML/CFT document link below or alternatively under the Investor Services Tab.

News

Follow us

20.03.19

Medical professionals have snapped up the rare opportunity to purchase office suites in Melbourne’s northern growth corridor, with MAB’s $18 million 7 Ormond development achieving strong sales results in its first release. Read more